- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT01263054
Safety and Efficacy of the TransDiscal System Versus Medical Management in Treating Chronic Discogenic Low Back Pain (COLD)
A Prospective, Randomized, Multi-Center, Open-Label Clinical Trial Comparing Disc Biacuplasty With Medical Management for Discogenic Lumbar Back Pain
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
The intervertebral discs serve as joints between the vertebral bodies, providing both structural support and flexibility to the spinal column. Intervertebral discs do not remain structurally intact over a lifetime and degenerate as a natural part of aging. Degenerated discs do not react to stresses and forces the same as healthy discs. When too much stress is applied to a degenerated disc, tears can result. Evidence suggests that when a tear is present, sensory nerve endings can grow into the tear and transmit pain.
The TransDiscal System (TDS) is a medical device that is used in a procedure called Disc Biacuplasty and is currently available in the United States and throughout the world. The TDS enables the back of the disc to be heated to high enough temperatures to ablate the nerves inside that are transmitting pain, while maintaining low enough temperatures to prevent damage to surrounding tissues. The TDS uses two electrodes, located at the ends of two thin probes, which are placed on both sides of the back of the intervertebral disc by inserting them through the skin into the disc using x-ray guidance. Radiofrequency (RF) current flows in the disc between the two electrodes, heating the tissue in the disc to the desired temperature. The study evaluates a modified heating protocol than what is currently in clinical use which should allow for a larger area of the back of the disc to be heated.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
District of Columbia
-
Washington, District of Columbia, Stany Zjednoczone, 20037
- George Washington University Hospital
-
-
Florida
-
Orlando, Florida, Stany Zjednoczone, 32806
- Compass Research
-
-
Illinois
-
Bloomington, Illinois, Stany Zjednoczone, 61701
- Millennium Pain Center
-
-
Maryland
-
Silver Spring, Maryland, Stany Zjednoczone, 20910
- Metro Orthopedics & Sports Therapy
-
-
New Jersey
-
Linwood, New Jersey, Stany Zjednoczone, 08221
- PainCare
-
-
North Carolina
-
Winston-Salem, North Carolina, Stany Zjednoczone, 27103
- Center for Clinical Research
-
-
Ohio
-
Cleveland, Ohio, Stany Zjednoczone, 44195
- Cleveland Clinic
-
-
Texas
-
Arlington, Texas, Stany Zjednoczone, 76018
- JPS Orthopedic & Sports Medicine
-
-
Washington
-
Seattle, Washington, Stany Zjednoczone, 98105
- Center for Pain Relief, University of Washington
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Age ≥21 years
- Able to understand the informed consent and able to complete outcome measures
- Objective measurements indicating functional impairment related to low back pain
- Stabilized on pain medication regimen for >2 months as defined by a <10% change in dosage
- History of chronic low back pain (>6 months) unresponsive to non-operative care (including physical therapy, anti-inflammatory medication, epidurals, diagnostic facet joint/medial branch blocks, and sacroiliac joint interventions as performed or deemed appropriate by the Investigator)
- Score ≥5 on the Visual Analog Scale (VAS) relating specifically to the average daily low back pain
- Back pain more prominent than leg pain which is commonly exacerbated by flexion or bending or prolonged sitting.
- Single level concordant pain reproduction present on lumbar discography in desiccated disc. Magnetic resonance Imaging (MRI) image also supports discography findings. Changes in other disc spaces in the lumbar region do not demonstrate neural compressive lesion.
- Disc height at least 50% of adjacent control disc
Exclusion Criteria:
- Evidence of compressive radiculopathy with predominant leg pain
- Evidence of nucleus pulposus herniation or free disc fragments on MRI
- Evidence of > 2 discs dessicated based on MRI or symptomatic involvement of more than one lumbar disc levels.
- Asymptomatic disc bulges > 5 mm at the treatment level.
- Prior lumbar surgery of any kind at the treatment level (micro-discectomies, and/or minimally invasive procedures at other levels that are not excluded)
- Prior spinal fusion below the T10 Level
- Symptoms or signs of lumbar canal stenosis at any level
- Evidence of structural abnormality at the lumbar level (except non-symptomatic spondylolysis resulting in spondylolithesis no more than Grade 1 upon flexion and extension)
- Any generalized pain or multifocal pain,conversion or multiple non-anatomical complaints
- Pending or active compensation claim, litigation or disability income remuneration (secondary gain)
- Chronic pain associated with significant psychosocial dysfunction
- Beck's Depression Index (BDI) score >20
- Current pregnancy, recent delivery (within 3 months of consent) or the intent of becoming pregnant during the study period.
- Systemic or localized infection at the anticipated needle entry site (subject may be considered for inclusion once infection is resolved)
- Discitis
- Allergies to any medication to be used in the procedure
- Present symptomatic lumbar spinal fracture
- History of uncontrolled coagulopathy, ongoing coagulation treatment or unexplained or uncontrollable bleeding that is uncorrectable
- Progressive neurological deficits
- Within the preceding 2 years, subject has suffered from active narcotic addiction, substance abuse or alcohol abuse
- Current prescribed opioid medications equivalent to >120 mg of morphine per 24 hours
- Uncontrolled immunosuppression (e.g. Acquired Immune Deficiency Syndrome [AIDS], cancer, diabetes, etc.)
- Body Mass Index (BMI) >32.5 kg/m^2
- Participating in another clinical trial/investigation 30 days prior to signing informed consent
- Negative or indeterminate lumbar discography results as assessed per International Spine Intervention Society (ISIS) guidelines
- Subject unwilling or unable to comply with follow up schedule or protocol requirements.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: TransDiscal System
Kimberly-Clark TransDiscal System in addition to standard medical management
|
Surgical Procedure using the TransDiscal System to perform disc biacuplasty.
Inne nazwy:
|
Inny: Medical Management
Standard medical management
|
Standard medical management, physical therapy, and lifestyle changes.
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Change in Average Daily Pain Visual Analog Scale (VAS) Score Between Screening and Follow up.
Ramy czasowe: Baseline and 6 months
|
Visual Analog Scale (NRS) - score range = 0 - 10. "0" corresponds to "no pain" and "10" indicates "worst pain imaginable".
The means of these scores and their respective standard deviations are reported for each study group.
|
Baseline and 6 months
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Percentage of Study Group Subjects With Greater Than 2 Points Decrease or 30% Drop in Average Daily Pain Related Visual Analog Scale (VAS) Score.
Ramy czasowe: Baseline and 6 months
|
Visual Analog Scale (NRS) - score range = 0 - 10. "0" corresponds to "no pain" and "10" indicates "worst pain imaginable".
The means of these scores and their respective standard deviations are reported for each study group.
|
Baseline and 6 months
|
Mean Change in Score of Short Form 36-Physical Functioning (SF36-PF) From Screening to 6 Month Follow up Visit
Ramy czasowe: Baseline and 6 months
|
Short Form 36-PF - score range = 0 - 100.
"0" corresponds to "greatest disability" and "100" indicates "no disability".
The means of these scores and their respective standard deviations are reported for each study group.
|
Baseline and 6 months
|
Mean Change in Score of EuroQuol 5d Visual Analog Scale (EQ-5d VAS) Between Screening and 6 Month Follow up Visit
Ramy czasowe: Baseline and 6 months
|
EQ-5d VAS - score range = 0 - 100.
"0" corresponds to the "worst imaginable health state" and "100" indicates the "best imaginable health state".
The means of these scores and their respective standard deviations are reported for each study group.
|
Baseline and 6 months
|
Mean Change in Score of Beck's Depression Inventory (BDI) Between Screening and 6 Month Follow up Visit
Ramy czasowe: Baseline and 6 months
|
BDI - score range = 0 - 63. "0" corresponds to "minimal depression" and "63" indicates "severe depression".
The means of these scores and their respective standard deviations are reported for each study group.
|
Baseline and 6 months
|
Mean Change in Score of Patient Global Impression of Change (PGIC) Between Screening and 6 Month Follow up Visit
Ramy czasowe: Baseline and 6 months
|
PGIC - score range = 1 - 7. "1" corresponds to "very much improved" and "7" indicates "very much worse" pertaining to overall activity, symptoms, emotions, and quality of life.
The means of these scores and their respective standard deviations are reported for each study group.
|
Baseline and 6 months
|
Mean Change in Score of Oswestry Disability Index (ODI) Between Screening and 6 Month Follow up Visit
Ramy czasowe: Baseline and 6 Months
|
ODI - score range = 0 - 100.
"0" corresponds to "no disability" and "100" indicates the "maximum disability possible".
The means of these scores and their respective standard deviations are reported for each study group.
|
Baseline and 6 Months
|
Współpracownicy i badacze
Sponsor
Śledczy
- Dyrektor Studium: David Curd, MS, Halyard Health, Inc.
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 100-10-0001
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Ból pleców
-
Université Victor Segalen Bordeaux 2Nanox International Laboratory (Belgique)ZakończonySkuteczność i tolerancja B-Back® na syndrom wypalenia zawodowegoFrancja
-
Herlev HospitalZakończonyChoroba niedokrwienna serca | Biofeed Back Guided Zarządzanie stresemDania
Badania kliniczne na TransDiscal System
-
Baylis Medical CompanyUniversity of AlbertaZakończony
-
Baylis Medical CompanyZakończonyBól dolnej części plecówStany Zjednoczone
-
CVRx, Inc.Zakończony
-
Baskent UniversityHacettepe UniversityZakończonyUżytkownik protezy | Sztuczne kończyny | AmputacjeIndyk
-
Angiodynamics, Inc.Zakończony
-
Zeltiq AestheticsZakończony
-
Smith & Nephew, Inc.ZakończonyOwrzodzenia stopy cukrzycowej | Owrzodzenia żylne nógStany Zjednoczone, Kanada
-
Buckinghamshire Healthcare NHS TrustNieznanyUraz rdzenia kręgowegoZjednoczone Królestwo
-
Zahedan University of Medical SciencesNieznanyBól, ból pooperacyjny Procesy patologiczne Powikłania pooperacyjne Oznaki i objawy
-
University of Missouri-ColumbiaTyco Healthcare GroupZakończony